ZA986336B - Medicaments comprising polyhydroxybutylpyrazines novel polyhydroxybutylpyrazines and their preparation - Google Patents

Medicaments comprising polyhydroxybutylpyrazines novel polyhydroxybutylpyrazines and their preparation

Info

Publication number
ZA986336B
ZA986336B ZA986336A ZA986336A ZA986336B ZA 986336 B ZA986336 B ZA 986336B ZA 986336 A ZA986336 A ZA 986336A ZA 986336 A ZA986336 A ZA 986336A ZA 986336 B ZA986336 B ZA 986336B
Authority
ZA
South Africa
Prior art keywords
polyhydroxybutylpyrazines
medicaments
novel
preparation
formulaincluding
Prior art date
Application number
ZA986336A
Other languages
English (en)
Inventor
Georges Bashiardes
Jean-Christophe Carry
Michel Evers
Bruno Filoche
Serge Mignani
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of ZA986336B publication Critical patent/ZA986336B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA986336A 1997-07-17 1998-07-16 Medicaments comprising polyhydroxybutylpyrazines novel polyhydroxybutylpyrazines and their preparation ZA986336B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9709059A FR2766183B1 (fr) 1997-07-17 1997-07-17 Medicaments contenant des polyhydroxybutylpyrazines, les polyhydroxybutylpyrazines nouvelles et leur preparation

Publications (1)

Publication Number Publication Date
ZA986336B true ZA986336B (en) 1999-01-27

Family

ID=9509301

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA986336A ZA986336B (en) 1997-07-17 1998-07-16 Medicaments comprising polyhydroxybutylpyrazines novel polyhydroxybutylpyrazines and their preparation

Country Status (25)

Country Link
US (1) US6288066B1 (de)
EP (1) EP1001942B1 (de)
JP (1) JP4443033B2 (de)
KR (1) KR20010021871A (de)
CN (1) CN1264368A (de)
AT (1) ATE243683T1 (de)
AU (1) AU745905B2 (de)
BR (1) BR9810595A (de)
CA (1) CA2296725C (de)
CZ (1) CZ290896B6 (de)
DE (1) DE69815854T2 (de)
DK (1) DK1001942T3 (de)
ES (1) ES2196595T3 (de)
FR (1) FR2766183B1 (de)
HU (1) HUP0004661A3 (de)
IL (1) IL134039A0 (de)
MX (1) MXPA00000437A (de)
NO (1) NO20000199L (de)
NZ (1) NZ502279A (de)
PL (1) PL338147A1 (de)
PT (1) PT1001942E (de)
RU (1) RU2186773C2 (de)
SK (1) SK462000A3 (de)
WO (1) WO1999003841A1 (de)
ZA (1) ZA986336B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2802813A1 (fr) * 1999-12-23 2001-06-29 Aventis Pharma Sa Association de deoxyfructosazine et d'un antidiabetique de la famille des biguandes
FR2802815A1 (fr) * 1999-12-23 2001-06-29 Aventis Pharma Sa Association de deoxyfructosazine et d'un antidiabetique agoniste du recepteur gamma-active par le proliferateur de peroxisome
FR2802816A1 (fr) * 1999-12-23 2001-06-29 Aventis Pharma Sa Association de deoxyfructosazine et d'un antidiabetique inhibiteur d'alpha-glucosidase
US6794506B2 (en) * 2000-07-21 2004-09-21 Elan Pharmaceuticals, Inc. 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
DE102005047647A1 (de) * 2005-10-05 2007-04-12 Merck Patent Gmbh a,a'-Dihydroxyketonderivate und deren Verwendung als UV-Filter
EP2121611B1 (de) 2007-03-19 2015-04-15 DSM IP Assets B.V. Auf alpha,beta-Dihydroxyketonen basierende UV-Filter-Verbindungen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2744365B1 (fr) * 1996-02-06 1998-02-27 Inst Malgache Rech Appl Melanges isolables a partir de graines d'eugenia jambolana lamarck, leur preparation et l'utilisation de ces melanges et certains de leurs constituants comme medicaments

Also Published As

Publication number Publication date
ATE243683T1 (de) 2003-07-15
EP1001942B1 (de) 2003-06-25
NO20000199D0 (no) 2000-01-14
PL338147A1 (en) 2000-09-25
CA2296725C (fr) 2008-11-18
IL134039A0 (en) 2001-04-30
DE69815854D1 (de) 2003-07-31
HUP0004661A3 (en) 2001-12-28
CZ290896B6 (cs) 2002-11-13
RU2186773C2 (ru) 2002-08-10
BR9810595A (pt) 2000-09-12
US6288066B1 (en) 2001-09-11
JP4443033B2 (ja) 2010-03-31
NO20000199L (no) 2000-01-14
AU745905B2 (en) 2002-04-11
DK1001942T3 (da) 2003-10-20
DE69815854T2 (de) 2004-05-13
AU8810398A (en) 1999-02-10
NZ502279A (en) 2002-04-26
WO1999003841A1 (fr) 1999-01-28
MXPA00000437A (es) 2002-04-17
PT1001942E (pt) 2003-11-28
CZ2000121A3 (cs) 2000-05-17
EP1001942A1 (de) 2000-05-24
SK462000A3 (en) 2000-06-12
FR2766183B1 (fr) 1999-08-27
FR2766183A1 (fr) 1999-01-22
KR20010021871A (ko) 2001-03-15
ES2196595T3 (es) 2003-12-16
CN1264368A (zh) 2000-08-23
JP2001510185A (ja) 2001-07-31
HUP0004661A2 (hu) 2001-11-28
CA2296725A1 (fr) 1999-01-28

Similar Documents

Publication Publication Date Title
SE9704546D0 (sv) Novel compounds
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
SE9704545D0 (sv) Novel compounds
SE9704544D0 (sv) Novel compounds
EE200000318A (et) Uudsed ühendid
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
MX9700885A (es) Nuevas heteroariloxazolidinonas.
SE9901875D0 (sv) Novel compounds
ZA965752B (en) Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents.
IL117091A0 (en) Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
IL134691A0 (en) Compounds containing six-membered rings, processes for their preparation, and their use as medicaments
MX9604762A (es) Nuevas sulfonamidas y procedimiento para su preparacion.
ZA986336B (en) Medicaments comprising polyhydroxybutylpyrazines novel polyhydroxybutylpyrazines and their preparation
ZA986680B (en) Thiazolobenzoheterocycles their preparation and medicaments containing them
NO903347L (no) 14,17alfa-ethano- og ethanooestratriener, fremgangsmaate forfremstilling av disse forbindelser, saavel som anvendelse av dem for fremstilling av legemidler.
SI0754680T1 (en) 4-Fluoroalkyl-substituted benzoylguanidines, process for their preparation, their use as medicament as well as medicaments containing them
ZA891435B (en) New trisubstituted amines,processes for their preparation as well as medicaments which contain these compounds
LTIP620A (en) Novel phospholipide derivatives
ZA986730B (en) Streptogramin derivatives their preparation and compositions containing them
MX9606264A (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol como sustancias farmacologicas activas.
BG102318A (en) Epoxy-azetidinons, their preparation and application
UA11675A1 (uk) 1-БЕtА-ОКСИЕТИЛАМІHО-3-КЕТО-5,5-ДИМЕТИЛЦИКЛОГЕКСЕH -1, ЯКИЙ МАЄ АHАЛЬГЕТИЧHУ АКТИВHІСТЬ
ZA9811804B (en) 11ß-halogen-7Ó-substituted estratrienes, process for the production of pharmaceutical preparations that contain these 11ß-halogen-7Ó-substituted estratrienes as well as their use for the production of pharmaceutical agents.